2006 media releases
| 23/11/2006 | Symbion Health 2006 Annual General Meeting The shareholders of Symbion Health approved all items of business put forward at the company's Annual General Meeting held in Melbourne today. |
| 01/11/2006 | Symbion Health Senior Management Changes Symbion Health is pleased to announce that Mark Hooper has been appointed to the role of Chief Financial Officer, effective 1 November 2006. |
| 21/09/2006 | Symbion Health ceases negotiations with Primary Health Care Symbion Health has today ceased negotiations with Primary Health Care to acquire its SDS Pathology business. |
| 14/09/2006 | Symbion Health confirms discussions with Primary Health Care Symbion Health notes the statement released to the ASX this morning by Primary Health Care. |
| 29/08/2006 | Symbion Health reports 12% increase in FY06 underlying earnings before interest and tax (EBIT) The demerger of Mayne Pharma Limited from Mayne Group Limited became effective on 18 November 2005, and Mayne Group Limited was renamed Symbion Health Limited. Symbion Health's reported results for FY06 include Mayne Pharma's results up until the date of the demerger, as well as costs associated with the demerger (transaction costs and Mayne Pharma impairment charge). Reported results are outlined in Table 3. |
| 14/07/2006 | Symbion Health successfully defends Sagacious claim Symbion Health Limited (formerly Mayne Group Limited) announced today it had successfully defended Supreme Court of NSW proceedings brought against it by Sagacious Procurement Pty Ltd. These proceedings commenced in 2002, when Sagacious alleged that Mayne wrongfully terminated its food procurement services contract with Mayne's former hospitals business. |
| 24/05/2006 | Symbion Health provides update on Healthscope litigation Symbion Health Limited today provided an update in relation to its proceedings in the Supreme Court of Victoria against the Healthscope Group. Symbion Health is claiming damages and injunctive relief against the Healthscope Group to protect its rights to be the exclusive provider of pathology services at four Healthscope hospitals where it leases pathology premises: John Fawkner and Northpark in Victoria; and Lady Davidson and The Hills in New South Wales. |
| 28/04/2006 | Symbion Health and NSW Office of State Revenue resolve payroll tax dispute Symbion Health Limited has welcomed the decision by the NSW Office of State Revenue to withdraw its assessments for payroll tax in respect of payments between the Company and General Practitioners (GPs) who operate their practices within Symbion Health's medical centre sites in NSW. |
| 16/03/2006 | Symbion Health reports steady improvement in underlying earnings before interest and tax (EBIT) for 1H06 Symbion Health Limited today announced a 10.0% increase in continuing business pre-securitisation earnings before interest, tax and significant items (EBIT) to $81.1 million for the six months ended 31 December 2005. Symbion Health's Directors declared an interim dividend of 4.0 cents per share, franked to 75%. |
| 27/01/2006 | Symbion Pharmacy Services restructure Symbion Health Limited today announced the departure of Group General Manager Pharmacy Services, Mr David Cranwell. |
